Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1979 2
1980 6
1981 5
1982 3
1983 3
1984 5
1985 7
1986 4
1987 16
1988 15
1989 17
1990 10
1991 9
1992 17
1993 15
1994 20
1995 30
1996 32
1997 21
1998 28
1999 28
2000 42
2001 44
2002 71
2003 73
2004 92
2005 123
2006 114
2007 106
2008 170
2009 175
2010 215
2011 244
2012 274
2013 340
2014 388
2015 457
2016 533
2017 496
2018 558
2019 576
2020 712
2021 785
2022 930
2023 916
2024 992
2025 1129
2026 582

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,239 results

Results by year

Filters applied: . Clear all
Page 1
Engineered immunosuppressive dendritic cells protect against cardiac remodelling.
Li X, Li J, Li G, Zhu L, Cheng G, Li H, Lin H, Jia N, Hong X, Liu Y, Zhong Z, Chen Y, Wang B, Zhao J, Hua Z, Wang L, Chen Q, Zheng P, Sheng S, Gu S, Ni C, Ye S, Ke C, Zhang F, Li M, Shi S, He J, Wu Y, Xu Y, Kong M, Chen Q, Li H, Zhang Y, Sun J, Hu G, Zhao C, Dong Y, Yu L, Xu Y, Hu X. Li X, et al. Among authors: hu g. Nature. 2026 May;653(8116):1205-1215. doi: 10.1038/s41586-026-10346-5. Epub 2026 Apr 8. Nature. 2026. PMID: 41951742
Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi.
Chen X, Duan HD, Hoy MJ, Koteva K, Spitzer M, Guitor AK, Puumala E, Fiebig AA, Hu G, Yiu B, Chou S, Bian Z, Choi Y, Guo ABY, Wang W, Sun S, Robbins N, Averette AF, Cook MA, Truant R, MacNeil LT, Brown ED, Kronstad JW, Coombes BK, Cowen LE, Heitman J, Li H, Wright GD. Chen X, et al. Among authors: hu g. Cell. 2026 Jan 22;189(2):620-639.e28. doi: 10.1016/j.cell.2025.11.036. Epub 2025 Dec 31. Cell. 2026. PMID: 41478284 Free PMC article.
Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.
Bao Z, Xue Y, Liu Y, Li S, Wang L, Qu Y, Mou Y, Yu R, Wu J, Yao Y, Shu K, Hu G, Cai L, Li W, Qiu X, Li Y, Zhang L, Qi S, Ji Y, Ma C, Ma W, Li G, Tao R, Sun C, Chen L, Lv SQ, Liang P, Pan H, Peter WYM, Danny CTM, Mao Q, Wei X, Jiang T. Bao Z, et al. Among authors: hu g. Cancer Commun (Lond). 2026 Mar 11;46:0019. doi: 10.34133/cancomm.0019. eCollection 2026. Cancer Commun (Lond). 2026. PMID: 41821581 Free PMC article. Clinical Trial.
Lifestyle factors and cardiometabolic risk.
Li W, Shen Y, Hu G. Li W, et al. Among authors: hu g. Chin Med J (Engl). 2026 Mar 5;139(5):636-652. doi: 10.1097/CM9.0000000000003991. Epub 2026 Jan 20. Chin Med J (Engl). 2026. PMID: 41558970 Free PMC article. Review.
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial.
You R, Xu GQ, Ding X, Liang JH, Liu ZG, Zou X, Liu YP, Hu GY, Liu YM, Duan CY, Liu LZ, Zhang WJ, Liu Q, Li HF, Ouyang YF, Duan XT, Wang Q, Peng L, Liang JL, Feng ZK, Qin ZH, Liu X, He ZK, Zhang B, Long GX, Jiang YH, Lei F, Huang PY, Hua YJ, Chen MY. You R, et al. Among authors: hu gy. BMJ. 2026 Feb 10;392:e085863. doi: 10.1136/bmj-2025-085863. BMJ. 2026. PMID: 41667193 Free PMC article. Clinical Trial.
10,239 results
You have reached the last available page of results. Please see the User Guide for more information.